Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Access Trends in Emerging Markets” report has been added to ResearchAndMarkets.com’s offering. Governments in emerging markets are under…
DUBLIN–(BUSINESS WIRE)–The “Access Trends in Emerging Markets” report has been added to ResearchAndMarkets.com’s offering. Governments in emerging markets are under…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Pancreatic Cancer” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the pancreatic…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Erectile Dysfunction” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Erectile…
Interest in large-scale Linear DNA for nucleic acid-based therapies continues to rise STONY BROOK, N.Y.–(BUSINESS WIRE)–$apdn #alzheimers–LineaRx, Inc. a wholly-owned…
MADISON, Wis.–(BUSINESS WIRE)–#CSR–Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices…
DUBLIN–(BUSINESS WIRE)–The “Combination Anti-diabetes Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Depressive Disorders: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. The Depressive…
Global 4WHIM trial marks first-ever Phase 3 study in patients with WHIM syndrome CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq:XFOR), a…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…